Page last updated: 2024-11-05

talactoferrin alfa and Necrotizing Enterocolitis

talactoferrin alfa has been researched along with Necrotizing Enterocolitis in 2 studies

talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006

Research Excerpts

ExcerptRelevanceReference
" Talactoferrin alfa (TLf) is a recombinant human Lf shown to protect against sepsis and necrotizing enterocolitis as well as cancer."3.80Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. ( Du, X; Jiang, R; Lönnerdal, B, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, R1
Du, X1
Lönnerdal, B1
Sherman, MP1
Adamkin, DH1
Niklas, V1
Radmacher, P1
Sherman, J1
Wertheimer, F1
Petrak, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants[NCT00854633]Phase 1/Phase 2120 participants (Anticipated)Interventional2009-06-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for talactoferrin alfa and Necrotizing Enterocolitis

ArticleYear
Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.
    The Journal of pediatrics, 2016, Volume: 175

    Topics: Administration, Oral; Bacteremia; Cross Infection; Double-Blind Method; Enterocolitis, Necrotizing;

2016

Other Studies

1 other study available for talactoferrin alfa and Necrotizing Enterocolitis

ArticleYear
Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.
    Journal of pediatric gastroenterology and nutrition, 2014, Volume: 59, Issue:5

    Topics: Animals; Apoptosis; Caco-2 Cells; Cattle; Cell Proliferation; Chemokine CCL20; Colonic Neoplasms; En

2014